Ying Jiang
-
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 3
-
- Cancer Immunotherapy and Biomarkers 6
- Cancer-related Molecular Pathways 3
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 6
-
- Ubiquitin and proteasome pathways 3
-
- Acute Myeloid Leukemia Research 3
- Cited by
- MicrobiologyPollutionCancer Research
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)Blood (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ying Jiang
101 papers receiving 662 citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Microbiology 5
- Pollution 63
- Cancer Research 66
- Oncology 115
- Industrial and Manufacturing Engineering 33
Countries citing papers authored by Ying Jiang
This map shows the geographic impact of Ying Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jiang more than expected).
Fields of papers citing papers by Ying Jiang
This network shows the impact of papers produced by Ying Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jiang. The network helps show where Ying Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2023 | 4 | |
| 18 | Relationship between serum trace elements and antioxidant capacity indexes in women of hypertensive disorder complicating pregnancy | 2016 | 2 |
| 19 | The Effect of Radiopacifier in Portland Cement for Repairing Furcal Perforations | 2016 | 5 |
| 20 | Solving Constraint Satisfaction Problem and Brief Introduction to ILOG SOLVER System | 2002 | 0 |
About Ying Jiang
Ying Jiang is a scholar working on Microbiology, Business and International Management and Oncology, having authored 119 papers that have together received 683 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Genomics and Diagnostics (3 papers), Acute Myeloid Leukemia Research (3 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Microbiology (5 citations), Pollution (63 citations) and Cancer Research (66 citations). Ying Jiang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Qin Zhou, Kun Yao, Lin Tian, Haohao Zhu, Zhiqiang Du, Zhenhe Zhou, Hui Gao, Mengqi He, Robert Amor and Jin Xu. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.